Conception
Berkeley
About Conception
Conception is a company developing the technology to turn skin cells into viable human eggs. This technology will give women the opportunity to have children well into their forties and fifties, eliminate barriers for couples suffering from infertility, and potentially allow male-male couples to have biological children. Long term, this technology could be a critical platform allowing for widespread genetic screening of embryos. If proven safe, it could even enable for genetic editing to eliminate and reduce the risk of devastating diseases for future generations – such as Alzheimer’s, heart disease and many different types of cancers. This could become one of the most important technologies ever created. The company was founded in 2018 and is headquartered in Berkeley, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $20.0M
- Last round: Series Unknown (Nov 2021)
- Website: conception.bio
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/conception-54044 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.